Get the Stockscreener App
1.70
2.41%
0.04
After Hours:
1.65
-0.05
-2.94%
Reneo Pharmaceuticals Inc stock is traded at $1.70, with a volume of 246.22K.
It is up +2.41% in the last 24 hours and up +14.86% over the past month.
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
See More
Previous Close:
$1.66
Open:
$1.67
24h Volume:
246.22K
Relative Volume:
1.44
Market Cap:
$56.67M
Revenue:
-
Net Income/Loss:
$-77.39M
P/E Ratio:
-0.7265
EPS:
-2.34
Net Cash Flow:
$-63.90M
1W Performance:
+23.19%
1M Performance:
+14.86%
6M Performance:
+2.41%
1Y Performance:
-77.68%
1-Day Range:
$1.65
$1.74
1-Week Range:
$1.38
$1.74
52-Week Range:
$0.9801
$9.21
Reneo Pharmaceuticals Inc Stock (RPHM) Company Profile
Name
Reneo Pharmaceuticals Inc
Sector
Industry
Phone
(858) 283-0280
Address
18575 JAMBOREE ROAD, IRVINE
Reneo Pharmaceuticals Inc Stock (RPHM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-23 | Initiated | H.C. Wainwright | Buy |
| Jul-03-23 | Initiated | BofA Securities | Buy |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jan-27-22 | Initiated | Robert W. Baird | Outperform |
| Dec-21-21 | Initiated | H.C. Wainwright | Buy |
| Nov-22-21 | Initiated | Ladenburg Thalmann | Buy |
| May-04-21 | Initiated | Jefferies | Buy |
| May-04-21 | Initiated | Piper Sandler | Overweight |
| May-04-21 | Initiated | SVB Leerink | Outperform |
View All
Reneo Pharmaceuticals Inc Stock (RPHM) Latest News
Reneo Pharmaceuticals Inc [RPHM] stock for 102,872 USD was bought by Leonard Braden Michael - Knox Daily
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Purchases 29,600 Shares - MarketBeat
Reneo Pharmaceuticals executive buys shares worth over $144k - Investing.com India
Reneo Pharmaceuticals executive buys shares worth over $144k By Investing.com - Investing.com Canada
Reneo Pharmaceuticals executive buys shares worth over $144k By Investing.com - Investing.com Australia
Analysts review Reneo Pharmaceuticals Inc’s rating - Knox Daily
RPHM’s 2023 Market Saga: Unraveling the Story of Gains and Losses - The InvestChronicle
Reneo Pharmaceuticals Inc (RPHM)’s Market Momentum: Closing Strong at 1.38, Down -8.00 - The Dwinnex
RCKT (Rocket Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
Analyzing Exicure (NASDAQ:XCUR) and Reneo Pharmaceuticals (NASDAQ:RPHM) - Defense World
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Purchases 55,300 Shares of Stock - Defense World
Holdings of Reneo Pharmaceuticals Inc (RPHM) are aligned with the stars - SETE News
Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying - MSN
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Shares Bought by Highbridge Capital Management LLC - Defense World
Reneo Pharmaceuticals executive buys over $76k in company stock By Investing.com - Investing.com South Africa
Reneo Pharmaceuticals executive buys over $76k in company stock - Investing.com
Reneo Pharmaceuticals executive buys over $76k in company stock - Investing.com India
Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
Reneo Pharmaceuticals Inc (RPHM) rating downgrades by Leerink Partners - Knox Daily
Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com Australia
Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com South Africa
Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com Canada
Reneo Pharmaceuticals executive buys shares worth over $484k - Investing.com
Reneo Pharmaceuticals executive buys shares worth over $484k By Investing.com - Investing.com UK
Market Resilience: Reneo Pharmaceuticals Inc (RPHM) Finishes Weak at 1.31, Down -7.09 - The Dwinnex
Reneo Pharmaceuticals Inc (RPHM) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Reneo Pharmaceuticals announces officer departure amid merger - Investing.com India
Reneo Pharmaceuticals announces officer departure amid merger - Investing.com
Reneo Pharmaceuticals Announces Merger and Executive Departure - TipRanks
Reneo Pharmaceuticals announces officer departure amid merger By Investing.com - Investing.com UK
Reneo Pharmaceuticals (NASDAQ:RPHM) Trading Down 0.7% - Defense World
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders - Business Wire
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc.RPHM - Business Wire
Braden Michael Leonard Acquires 171,339 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Stock - Defense World
Reneo Pharmaceuticals insider buys shares worth over $380k By Investing.com - Investing.com South Africa
Reneo Pharmaceuticals insider buys shares worth over $380k By Investing.com - Investing.com Australia
Citizens And 2 Other Penny Stocks Insiders Are Buying - Benzinga
Reneo Pharmaceuticals insider buys shares worth over $380k By Investing.com - Investing.com India
Reneo Pharmaceuticals insider buys shares worth over $380k - Investing.com
Reneo Pharmaceuticals insider buys shares worth over $380k By Investing.com - Investing.com Canada
Reneo Pharmaceuticals insider buys shares worth over $380k By Investing.com - Investing.com UK
Reneo Pharmaceuticals Inc [RPHM] Insider Activity: An Update for Investors - Knox Daily
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024 - InvestorPlace
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results - GlobeNewswire
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results - Yahoo Finance
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results - StockTitan
VTVTvTv Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
Brokerages Set Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Price Target at $11.01 - MarketBeat
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Rating of “Reduce” from Analysts - Defense World
Reneo Pharmaceuticals Inc (RPHM) is looking forward to a strong quarter – Sete News - SETE News
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Reneo Pharmaceuticals Inc Stock (RPHM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):